Showing results (751-760 of 1,301) with videos related to

Sort By:
Pageof 131
JAMA Cardiology|August 10, 2021
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A ReviewJohn G Rizk, Aashish Gupta, Partha Sardar, et al.
JAMA Cardiology|August 10, 2021
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of ChildrenAudrey Dionne, Francesca Sperotto, Stephanie Chamberlain, et al.
JAMA Cardiology|August 25, 2021
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection FractionOmar F AbouEzzeddine, Daniel R Davies, Christopher G Scott, et al.
JAMA Cardiology|August 25, 2021
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary SyndromeGorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
JAMA Cardiology|May 12, 2021
Association of Systolic Blood Pressure Elevation With Disproportionate Left Ventricular Remodeling in Very Preterm-Born Young Adults: The Preterm Heart and Elevated Blood PressureAfifah Mohamed, Maciej Marciniak, Wilby Williamson, et al.
JAMA Cardiology|May 21, 2020
Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical TrialRoxana Mehran, Jaya Chandrasekhar, Philip Urban, et al.
JAMA Cardiology|April 23, 2020
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical TrialMona Fiuzat, Justin Ezekowitz, Wendimagegn Alemayehu, et al.
JAMA Cardiology|April 30, 2020
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER TrialBrian A Bergmark, Michelle L O'Donoghue, Sabina A Murphy, et al.
JAMA Cardiology|September 8, 2021
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia GenesZachary T Yoneda, Katherine C Anderson, Joseph A Quintana, et al.
Pageof 131